Sanofi
SNYNF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001121404
No open-market purchases or sales by Sanofi insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2.52M in total; no superinvestor holds it.
Other share classesSNY
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 2
- 13F valueReported value at the end of Q2 2026
- $2.52M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding SNYNF, Q2 2026
No superinvestor reported holding SNYNF at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Sanofi insiders from Form 4, newest first.
No open-market purchases or sales by Sanofi insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Sanofi at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Generali Investments CEE, investicni spolecnost, a.s. | 29,339 | $2.52M | 0.12% | +564+2.0% | Added |
| GAMMA Investing LLC | 58 | $4.85K | 0.00% | −248−81.0% | Reduced |